NCT06007937 2026-02-05A Study of Lorlatinib in Combination With Ramucirumab in People With Lung CancerMemorial Sloan Kettering Cancer CenterPhase 1/2 Recruiting56 enrolled
NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled